| Catalog No. | HP115016 |
| Brand | abinScience |
| Host species | Human |
| Species reactivity | General |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Purity | >95% purity as determined by SDS-PAGE. |
| Clonality | Monoclonal |
| Isotype | IgG |
| Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo |
| Target | Ganglioside GD2 |
| References | 1. Nazha B, et al. Disialoganglioside GD2 Expression in Solid Tumors and Role as a Target for Cancer Therapy. Front Oncol. 2020;10:1000. Published 2020 Jul 7. [HP115016] 2. Erber R, et al. Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes. Cancers (Basel). 2021;13(21):5577. Published 2021 Nov 8. [HP115016] |
| Purification | Protein A/G purified from cell culture supernatant. |
| Biological activity | Ganglioside GD2 is associated with tumor development and malignant phenotypes, and its mechanism of action involves enhancing cell proliferation, motility, migration, adhesion and invasion, with specific effects depending on tumor type [1]. |
| Endotoxin level | < 10 EU/mg |
| Expression system | Mammalian cells |
| Accession | CAS: 65988-71-8 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Alternative name | ATL301 |
| Clone ID | ATL301 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
Anti-Ganglioside GD2 Reference Antibody (ATL301, RUO)
Overview
Images
 SDS-PAGE |
SDS-PAGE for Research Grade Anti-Ganglioside GD2 (ATL301) |